Recent studies have implicated glial cells in novel physiological roles in the CNS, such as modulation of synaptic transmission, so it is possible that glial cells might have a functional role in the hyperexcitability that is characteristic of epilepsy. Indeed, alterations in distinct astrocyte membrane channels, receptors and transporters have all been associated with the epileptic state. This paper focuses on the potential roles of the glial water channel aquaporin-4 (AQP4) in modulating brain excitability and in epilepsy. We review studies of seizure phenotypes, K + homeostasis and extracellular space physiology of mice that lack AQP4 (AQP4 2/2 mice) and discuss the human studies demonstrating alterations of AQP4 in specimens of human epilepsy tissue. We conclude with new studies of AQP4 regulation by seizures and discuss its potential role in the development of epilepsy (epileptogenesis). Although many questions remain unanswered, the available data indicate that AQP4 and its molecular partners might represent important new therapeutic targets.
INTRODUCTION

Glial cells and epilepsy
Epilepsy, which affects ,1% of the population, comprises a group of disorders of the brain that are characterized by the periodic and unpredictable occurrence of seizures. It is clear that epilepsy is a major public health problem in that those affected experience the periodic and unpredictable occurrence of seizures leading to impairment of consciousness. This handicap severely impairs the performance of many tasks and, secondarily, the procurement and maintenance of steady employment. Elucidating the cellular and molecular mechanisms of seizure generation might lead to novel antiepileptic drug (AED) therapies.
Most current existing AEDs act on widely expressed ion channels that directly control neuronal excitability (Rogawski and Loscher, 2004) . For example, Na + channel blockers (e.g. phenytoin) reduce the rate and/or rise of neuronal action potentials and, thus, inhibit high-frequency neuronal firing. GABA receptor agonists (e.g. phenobarbital) increase the efficacy of GABAergic synapses, thus, increasing inhibitory synaptic transmission. These existing medications have at least two major drawbacks. First, even with optimal current AED therapy, ,30% of patients have poor seizure control and become medically refractory. Secondly, because these medications act as general CNS depressants and must be taken chronically for seizure suppression, they also have marked inhibitory effects on cognition and cognitive development.
Glial cells are involved in many important physiological functions, such as sequestration and/or redistribution of K + during neural activity, neurotransmitter cycling and provision of energy substrates to neurons (Ransom et al., 2003) . Several recent lines of evidence strongly indicate that glial cells are potential novel targets for epilepsy (Binder and Steinhäuser, 2006) . First, many studies now link glial cells to modulation of synaptic transmission (Volterra and Steinhäuser, 2004; Volterra and Meldolesi, 2005) . Secondly, functional alterations of specific glial membrane channels and receptors have been discovered in epileptic tissue (Heinemann et al., 2000; Hinterkeuser et al., 2000; Kivi et al., 2000; Steinhäuser and Seifert, 2002; de Lanerolle and Lee, 2005; Seifert et al., 2006) . Thirdly, direct stimulation of astrocytes is sufficient for neuronal synchronization in epilepsy models (Tian et al., 2005) , although see also Fiacco et al. (2007) . Thus, if the cellular and molecular mechanisms by which glial cells (especially astrocytes) modulate excitability are better understood, specific antiepileptic therapies based selectively on modulation of glial receptors and channels that are likely to have fewer deleterious side effects can be contemplated.
Aquaporins
The aquaporins (AQPs) are a family of membrane proteins that function as 'water channels' in many cell types and tissues in which fluid transport is crucial (AmiryMoghaddam and Ottersen, 2003; Verkman, 2005) . The AQPs are small hydrophobic integral membrane proteins (,30 kDa monomer) that facilitate bidirectional water transport in response to osmotic gradients (Verkman, 2002) . Multiple mammalian AQPs have been identified including AQP0, AQP1, AQP2, AQP4 and AQP5, which transport water only (AQPs), and AQP3, AQP7 and AQP9, which also transport glycerol (aquaglyceroporins) (Agre et al., 2002; Verkman, 2002) .
AQP4 (Hasegawa et al., 1994; Jung et al., 1994; Yang et al., 1995) is of particular interest in neuroscience because it is expressed in brain and spinal cord by glial cells, especially at specialized membrane domains including astroglial endfeet in contact with blood vessels and astrocyte membranes that ensheathe glutamatergic synapses (Nielsen et al., 1997; Rash et al., 1998; Nagelhus et al., 2004; Oshio et al., 2004) . Activityinduced radial water fluxes in the neocortex have been demonstrated that might represent water movement via AQP channels in response to physiological activity (Holthoff and Witte, 2000; Niermann et al., 2001) . Interestingly, AQP4 is a structural component of membrane orthogonal arrays of particles (OAPs) seen in freeze-fracture electron micrographs (Frigeri et al., 1995; Yang et al., 1996; Verbavatz et al., 1997) .
AQP4
2/2 mice AQP4 2/2 mice were generated by targeted gene disruption in 1997 (Ma et al., 1997) . These mice are grossly normal phenotypically, do not manifest overt neurological abnormalities, altered blood-brain barrier properties, abnormal baseline intracranial pressure, impaired osmoregulation or obvious brain dysmorphology (Fig. 1) . They have normal blood chemistries and hematologies, normal expression of other brain AQPs (AQP1 and AQP9) and their only nonneural phenotype is a mild impairment in maximal urineconcentrating ability (Ma et al., 1997) .
Interestingly, more detailed studies of brain tissue from AQP4
2/2 mice demonstrate reduced osmotic water permeability as measured in isolated membrane vesicles (Ma et al., 1997), brain slices (Solenov et al., 2002) and intact brain (Thiagarajah et al., 2005) . Also, water permeability is reduced seven-fold in primary astrocyte cultures from AQP4 2/2 mice as measured by a calcein fluorescence-quenching method (Solenov et al., 2004) , and similar results have been obtained with AQP4 RNAi knockdown experiments in wild-type astrocytes (Nicchia et al., 2003) . These data demonstrate directly that AQP4 provides the predominant pathway for transmembrane water movement in astrocytes.
In vivo studies of these mice demonstrated a functional role for AQP4 in brain water transport. AQP4 2/2 mice have markedly decreased accumulation of brain water (cerebral edema) following water intoxication and focal cerebral ischemia (Manley et al., 2000) and impaired clearance of brain water in models of vasogenic edema . This corresponds to impaired water flux into (in the case of cytotoxic edema) and out of (in the case of vasogenic edema) the brain, which makes sense based on the bidirectional nature of water flux across the AQP4 membrane channel at the blood-brain barrier . Similarly, mice deficient in dystrophin or a-syntrophin, in which there is mislocalization of the AQP4 protein (Frigeri et al., 2001; Neely et al., 2001; Vajda et al., 2002) , also demonstrate attenuated cerebral edema (Vajda et al., 2002; Amiry-Moghaddam et al., 2003a) .
Altered extracellular space in AQP4
2/2 mice
We also hypothesized that the physiology of the extracellular space (ECS) in the brain might be altered in AQP4 2/2 mice because of impaired glial water uptake. The ECS in the brain comprises ,20% of brain tissue volume, consisting of a jellylike matrix in which neurons, glia and blood vessels are embedded (Sykova, 1997) . The ECS contains ions, neurotransmitters, metabolites, peptides and extracellular matrix molecules, forming the microenvironment for all cells in the brain and mediating glia-neuron communication via diffusible messengers, metabolites and ions (Fields and StevensGraham, 2002) . To examine the physiology of the ECS in vivo, we have developed and validated a novel cortical fluorescence recovery after photobleaching (cFRAP) method to measure the diffusion of fluorescently-labeled macromolecules in the cortex (Binder et al., 2004b) . ECS in mouse brain was labeled by exposure of the intact dura to fluorescein-dextrans (M r 4 kD, 70 kD and 500 kD) after craniectomy ( Fig. 2A) . Fluorescein-dextran diffusion was detected by fluorescence recovery after laser-induced cortical photobleaching using confocal optics (Fig. 2B) . FITC-dextran diffusion was slowed ,three-fold in brain ECS relative to solution (Fig. 2C) . The cortical photobleaching approach was applied to brain edema, seizure initiation and AQP4 deficiency. Cytotoxic brain edema (produced by water intoxication) or seizure activity (produced by convulsants) slowed diffusion by .10-fold and created dead-space microdomains in which free diffusion was prevented (not shown). The hindrance to diffusion was greater for the larger fluorescein dextrans. Interestingly, slowed ECS diffusion preceded electroencephalographic seizure activity ( Fig. 3) (Binder et al., 2004b) . In contrast to the slowed diffusion produced by brain edema and seizure activity, ECS diffusion was faster in AQP4 2/2 mice (Fig. 2D) , indicating ECS expansion in AQP4 deficiency. In follow-up studies, cortical surface photobleaching has been used to demonstrate accelerated macromolecule diffusion in the expanded ECS in vasogenic edema .
Seizure phenotype of AQP4
Chemoconvulsant studies
In view of the role of AQP4 in cerebral water balance and ECS physiology, we aimed to test seizure phenotypes in AQP4 2/2 mice. Seizure susceptibility has been examined using the convulsant (GABA antagonist) pentylenetetrazol (PTZ) (Binder et al., 2004a) . At 40 mg kg 21 PTZ (i.p.), all wild-type mice exhibited seizure activity, whereas 6 out of 7 AQP4 2/2 mice did not exhibit seizure activity. At 50 mg kg 21 PTZ, both groups exhibited seizure activity; however, the latency to generalized (tonic-clonic) seizures was longer in AQP4 2/2 mice (Binder et al., 2004a) . Seizure propensity is exquisitely sensitive to ECS volume (Schwartzkroin et al., 1998) , so we hypothesized that the expanded ECS in AQP4 deficient mice is responsible for the increased seizure threshold. Thus, more intense stimuli (e.g. either higher PTZ doses or a longer time after PTZ) might be required to overcome the expanded ECS of AQP4 2/2 mice in order to initiate a seizure.
Electrical stimulation in vivo
In order to analyze the seizure phenotype of AQP4 2/2 mice in greater detail, we employed in vivo electroencephalographic (EEG) characterization with stimulation and recording . AQP4 2/2 mice and wild-type controls were implanted in the right dorsal hippocampus with bipolar electrodes. Following postoperative recovery, electrical stimulations were given to assess electrographic seizure threshold and duration. Mice were awake and freely moving at the onset of stimulation (Fig. 4A ). Baseline EEG in wild-type and AQP4 2/2 mice was indistinguishable, and there was no difference in baseline EEG power spectra (data not shown). Representative examples of hippocampal stimulation-evoked seizures for wild-type versus AQP4 2/2 mice are shown in Fig. 
4B. AQP4
2/2 mice have a higher mean electrographic seizure threshold (167 ± 17 mA) than wild-type controls (114 ± 10 mA) (P,0.01) (Fig. 4C) , consistent with the earlier PTZ studies (Binder et al., 2004a) . In addition, AQP4 2/2 mice have more prolonged stimulation-evoked seizures (33 ± 2 sec) compared to wild-type controls (13 ± 2 sec) (Fig. 4D ). The only change in behavior during seizures (in both genotypes) is postural immobility (Grade 1 in the Racine classification) (Racine, 1972) .
More impressive than the effect on seizure threshold is the nearly three-fold increase in seizure duration in AQP4
2/2 mice. We hypothesized that the absence of AQP4 was associated with impaired K + reuptake. Impaired K + clearance from the ECS following the intense neuronal activity accompanying the seizure would lead to prolonged depolarization of neurons and inhibit seizure termination (Rutecki et al., 1985; Yaari et al., 1986; Traynelis and Dingledine, 1988; Steinhäuser and Seifert, 2002) . Indeed, in addition to modulating water transport in the brain, AQP4 and its known molecular partners have been hypothesized to modulate ion homeostasis Simard and Nedergaard, 2004) . During rapid neuronal firing, extracellular [K + ] increases from ,3 mM to a maximum of 10-12 mM; and K + released by active neurons is thought to be primarily taken up by glial cells (Heinemann and Lux, 1977; Sykova, 1997; Xiong and Stringer, 1999; Somjen, 2002) . Such K + reuptake into glial cells might be AQP4-dependent because water influx coupled to K + influx is thought to underlie activity-induced glial cell swelling (Walz, 1987; Walz, 1992) . In support of this possibility is the subcellular colocalization of AQP4 with the inwardly rectifying K Rozengurt et al., 2003) . K ir 4.1 is thought to contribute to K + reuptake and spatial K + buffering by glial cells (Newman et al., 1984; Newman, 1986; Newman and Karwoski, 1989; Newman, 1993) , and pharmacological or genetic inactivation of K ir 4.1 leads to impairment of extracellular K + regulation (Ballanyi et al., 1987; Kofuji et al., 2000; Kofuji and Newman, 2004; Neusch et al., 2006; Djukic et al., 2007) .
To address the possibility that AQP4 deficiency was associated with a deficit in K + homeostasis, we examined K + dynamics in vivo in AQP4 2/2 mice . K + measurements were made from intact cortex with doublebarreled K + -sensitive microelectrodes (Fig. 5A ). Before and after each in vivo measurement, K + calibration curves were measured (Fig. 5B) . Stimulation produced an amplitudedependent rise in [K + ] o that rapidly returned to baseline over a few seconds (Fig. 5C) (Heinemann and Lux, 1977; Somjen, 2002) were altered in AQP4 deficiency, indicating 2/2 mouse (bottom). The wild-type mouse had an 11-sec seizure, whereas the AQP4 2/ 2 mouse had a much longer seizure (37 secs). Behavioral arrest was observed in both animals during the seizure. Post-ictal depression is evident on the EEG in both cases. (C) Electrographic seizure threshold (mA) (mean ± SEM) in WT vs. AQP4 2/2 mice. AQP4 2/2 mice had a higher electrographic seizure threshold than wild-type controls. (D) Electrographic seizure duration (sec) (mean ± SEM) following hippocampal stimulation in wild-type and AQP4 2/2 mice. AQP4 2/2 mice had longer stimulation-evoked seizures compared to wild-type controls. From . that basic K + homeostasis was intact. However, there was a distinction in kinetics, with marked delay in rise and decay time. A similar delay in K + kinetics was observed following cortical spreading depression in AQP4 2/2 mice using a fluorescent K + sensor (Padmawar et al., 2005 Mice deficient in a-syntrophin, an adapter protein in the dystrophin-containing protein complex (Neely et al., 2001) , manifest altered subcellular distribution of AQP4, and afferent stimulation of hippocampal slices from asyntrophin-deficient mice also demonstrated a deficit in extracellular K + clearance following evoked neuronal activity (Amiry- Moghaddam et al., 2003b) . Together with our findings, these data indicate that AQP4 and its molecular partners together comprise a multifunctional 'unit' responsible for clearance of K + and/or H 2 O following neural activity.
Water and K + dysregulation in seizure susceptibility and in human epilepsy
Modulation of water and K
+ homeostasis by AQP4 might dramatically affect seizure susceptibility. First, brain tissue excitability is exquisitely sensitive to osmolarity and the size of the ECS (Schwartzkroin et al., 1998) . Decreasing ECS volume produces hyperexcitability and enhanced epileptiform activity (Dudek et al., 1990; Roper et al., 1992; Chebabo et al., 1995; Pan and Stringer, 1996) ; conversely, increasing ECS volume with hyperosmolar medium attenuates epileptiform activity (Traynelis and Dingledine, 1989; Dudek et al., 1990; Pan and Stringer, 1996; Haglund and Hochman, 2005) . These experimental data parallel extensive clinical experience indicating that hypo-osmolar states such as hyponatremia lower seizure threshold whereas hyperosmolar states elevate seizure threshold (Andrew et al., 1989) . Second, millimolar and even submillimolar increases in extracellular K + concentration powerfully enhance epileptiform activity in the hippocampus (Rutecki et al., 1985; Yaari et al., 1986; Traynelis and Dingledine, 1988; Feng and Durand, 2006) . High-K + reliably induces epileptiform activity in hippocampal slices from humans with intractable temporal lobe epilepsy (Gabriel et al., 2004) .
The most common pathology in patients with medicallyintractable temporal lobe epilepsy is mesial temporal sclerosis (MTS), which is characterized by marked neuronal cell loss in specific hippocampal areas, gliosis, and microvascular proliferation (Blümcke et al., 1999) . Emerging work also demonstrates dysregulation of water and K + homeostasis in patients with MTS. First, imaging studies demonstrate abnormal T2 prolongation by MRI in the epileptic hippocampus, thought to be due to increased water content (Mitchell et al., 1999) . This is accompanied by alterations in apparent diffusion coefficient (ADC) with diffusion-weighted MRI imaging (Hugg et al., 1999 Dysfunction of astroglial K ir channels has also been found in specimens from patients with temporal lobe epilepsy (Heinemann et al., 2000; Steinhäuser and Seifert, 2002) . First, using ion-sensitive microelectrodes, Kivi et al. demonstrated an impairment of glial barium-sensitive K + uptake in the CA1 region of MTS specimens (Kivi et al., 2000) . Secondly, using patch-clamp analysis, Hinterkeuser et al. demonstrated a dramatic reduction in astroglial K ir currents in MTS tissue (Hinterkeuser et al., 2000) . Reduction in K ir currents is expected to contribute to hyperexcitability; excellent recent evidence for this comes from the finding of stress-induced seizures in conditional K ir 4.1 2/2 mice from Ken McCarthy's laboratory (Djukic et al., 2007) .
Disruption of the dystrophin-associated protein complex
A key potential mechanism for altered subcellular distribution of AQP4 during epileptogenesis is disruption of the dystrophin-associated protein complex (DAPC), which has an essential role in anchoring of AQP4 at the perivascular astrocyte membrane. First, in dystrophin-null transgenic (mdx) mice, immunofluorescence and immunoelectron microscopic analyses revealed a dramatic reduction of AQP4 in astroglial endfeet surrounding capillaries and at the glia limitans (cerebrospinal fluid-brain interface) despite no alteration in total AQP4 protein (Vajda et al., 2002) . Secondly, mice deficient in a-syntrophin, an adapter protein associated with dystrophin (Neely et al., 2001) , show marked loss of AQP4 from perivascular and subpial membranes as judged by quantitative immunogold electron microscopy (Amiry- Moghaddam et al., 2003a) . These studies indicate that alterations in components of the DAPC might secondarily affect the subcellular targeting and function of AQP4. In this regard, a-syntrophin-deficient mice also demonstrated a deficit in extracellular K + clearance following evoked neuronal activity (Amiry-Moghaddam et al., 2003b) . A recent study also demonstrates that dystrophin localization at the astrocytic endfoot is dependent on syntrophin (Bragg et al., 2006) .
What are the functional consequences of loss of dystrophin or syntrophin on seizure susceptibility? Dystrophin-null (mdx) mice have altered seizure susceptibility in response to various chemical convulsants; in particular, mdx mice show enhanced seizure severity and a shorter latency in the development of chemical kindling produced by administration of PTZ (De Sarro et al., 2004) . Mice deficient in a-syntrophin were found to have an increased intensity of hyperthermia-evoked seizures (AmiryMoghaddam et al., 2003b) . It is interesting to note that there is an increased incidence of epilepsy in forms of human muscular dystrophy in which this complex is affected (Tsao and Mendell, 2006) .
Disruption of the DAPC has also been demonstrated in human epileptic tissue. In the study in which reduced perivascular membrane expression of AQP4 was noted (Eid et al., 2005) , the authors also studied perivascular dystrophin expression. Like AQP4 expression, perivascular dystrophin expression is reduced in tissue from the sclerotic epileptic hippocampus (Eid et al., 2005) . Thus, subcellular alteration in AQP4 expression might result from alterations in dystrophin and/or other members of the DAPC.
Methodological issues
When assessing the contribution of AQP4 and its molecular partners to epileptogenesis it is necessary to examine the methodology in the reported studies. First, studies of human tissue represent the 'endpoint' of an already long-standing epileptogenic process. A sclerotic hippocampus with significant neuronal cell loss and gliosis might show many molecular changes in glial cells including the reported altered distribution of AQP4 (Lee et al., 2004; Eid et al., 2005) , but what is unclear from these studies is whether dysregulation of AQP4 represents a cause or consequence of epileptogenesis. Appropriate animal models of epilepsy permit dissection of the process of epileptogenesis in greater detail. In particular, in such models it is possible to examine the transition from a normal to an epileptic brain as assessed by in vivo electrophysiological recordings of spontaneous seizures following an initial epileptogenic insult. Description of the molecular changes in glial cells during epileptogenesis is still in its infancy (Binder and Steinhäuser, 2006 ), but will be facilitated by studies in such in vivo models. Unlike in vivo models, studies with ex vivo slices enable the delineation of tissue and synaptic physiology in greater detail (AmiryMoghaddam et al., 2003b) but at the expense of isolating only a part of the in vivo network. Thus, a fruitful combination of methodologies for future study will include in vivo electrophysiological recording for validation of epileptogenesis, ex vivo slice physiology, and examination of the cellular and molecular changes in glial cells leading up to the development of spontaneous seizures.
Unanswered questions
The studies discussed above indicate novel roles for AQP4 in the control of seizure susceptibility (Binder et al., 2004a; , K + homeostasis (Padmawar et al., 2005; and ECS physiology (Binder et al., 2004b) . These findings, together with the changes in human epileptic tissue (Lee et al., 2004; Eid et al., 2005) , lead to the unifying hypothesis that AQP4 and its molecular partners might have a functional role in epilepsy (Dudek and Rogawski, 2005) . In this context, and based on the recent burgeoning literature on glial-neuronal interactions and gliovascular interactions, several fascinating unanswered questions arise including:
N What is the expression pattern of AQP4 within the hippocampus, a structure that is crucial to epileptogenesis? Early studies have demonstrated the perivascular localization of AQP4 (Nielsen et al., 1997; Badaut et al., 2000; Badaut et al., 2002; Nagelhus et al., 2004) but did not examine the region-specific expression of AQP4 in the brain in detail.
N What are the cellular/molecular events that cause AQP4 upregulation during epileptogenesis? Seizure activity is accompanied by a variety of changes in gene expression, and either repeated or prolonged seizure activity leads to glial changes, ultimately including the proliferation of 'reactive' astrocytes (gliosis). Previous studies indicate upregulation and altered distribution of AQP4 protein in sclerotic tissue resected from patients with MTS (Lee et al., 2004; Eid et al., 2005) . However, it is unclear whether AQP4 is upregulated by seizure activity per se and/or by other processes occurring during epileptogenesis (development of epilepsy), such as cell death, inflammation and gliosis (Vezzani and Granata, 2005) . AQP4 is upregulated dramatically in reactive astrocytes following injury (Vizuete et al., 1999; Saadoun et al., 2002; Badaut et al., 2003) but might also be regulated by physiological stimuli (Saito et al., 2005) . To date, no studies of seizure regulation of AQP4 have been reported in animal models. Distinct epilepsy models in which epileptogenesis occurs in the absence of detectable cell death would be useful in determining the threshold for AQP4 regulation (Bender et al., 2004; Dubé et al., 2007) .
N What is the time course of AQP4 regulation? Whether AQP4 regulation either precedes or follows epileptogenesis impacts its functional role as cause or consequence. To address this question requires concurrent video-EEG monitoring during epileptogenesis to determine the exact time of onset of spontaneous seizures.
N What is the cell type-specificity of AQP4 expression and regulation? Colocalization with glial markers will be crucial to determine cell type-specificity. The description of novel classes of hippocampal glial cells (GluT and GluR cells) with different morphology and functional properties (Matthias et al., 2003; Wallraff et al., 2004; Jabs et al., 2005; Nishiyama et al., 2005) makes it particularly important to clearly identify which 'glial cell' expresses AQP4. Whereas AQP4 is thought to be expressed predominantly by 'classical' astrocytes (GluT cells), some have reported expression in other cell types, such as microglia (TomasCamardiel et al., 2004) .
N How does the regulation of AQP4 relate to angiogenesis during epileptogenesis? It is known that epileptic tissue contains many more microvessels, probably caused partly by upregulation of vascular endothelial growth factor (VEGF) following seizures (Croll et al., 2004; Nicoletti et al., 2008; Rigau et al., 2007) . Recently, administration of VEGF itself has been shown to upregulate AQP4 (Rite et al., 2007) , and it will be interesting to study whether AQP4 distribution and/or function may be unique in 'epileptic vasculature'. In this regard, recent studies convincingly demonstrate astrocyte control of cerebrovascular tone (Gordon et al., 2007) .
N In a related question, what is the subcellular distribution of AQP4 at the astroglial endfeet following epileptogenesis and how might subcellular redistribution of AQP4 affect water and K + homeostasis in the epileptic brain? Might either improved targeting or localization of AQP4 be an effective therapy in an epileptic brain? A recent study shows that the extracellular matrix protein agrin might be a crucial regulator of AQP4 membrane trafficking and polarity (Noell et al., 2007) .
N Seizure regulation of AQP4 expression does not prove pathophysiological significance. Comparing the rate of epileptogenesis in wild-type and AQP4
2/2 mice with quantitative, in vivo, real-time video-EEG recording would help to provide functional evidence for a role of AQP4 as either pro-or anti-epileptogenic. If fruitful, these experiments might lead to the concept of AQP modulation as a novel antiepileptic strategy. As pharmacological activators/ inhibitors of AQP4 become available they can be tested in relevant animal models.
CONCLUSIONS
Compelling evidence indicates that the glial water channel AQP4 has a fundamental role in water transport in the brain. AQP4 is expressed in astrocytes and, along with the inwardlyrectifying K + channel K ir 4.1, is thought to underlie the reuptake of H 2 O and K + into glial cells during neural activity. Because osmolarity and K + have powerful effects on seizure susceptibility, AQP4 and its molecular partners might represent novel therapeutic targets for the control of seizures. Transgenic mice that lack AQP4 have significantly prolonged seizure duration, which is associated with a deficit in extracellular K + clearance. The available human studies indicate dysfunctional K + homeostasis in human epileptic tissue, and upregulation and altered subcellular distribution of AQP4. The relevance of these findings to hippocampal epileptogenesis and to human epilepsy requires further study. Restoration of water and K + homeostasis in epileptic tissue constitutes a novel therapeutic concept. AQP4 occupies a pivotal position: concentrated in both astrocytic endfeet and in astroglial processes investing synapses, it might be involved in glial-neuronal interaction of water and ion fluxes and in glial-vascular interactions across the blood-brain barrier. Thus, together with its molecular partners, it might havea crucial role both during active tissue metabolism and in pathophysiological states.
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